We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Enzon Pharmaceuticals Inc.s financial performance into perspective.
Enzon Pharmaceuticals Inc. is currently followed by the brokerage firms listed above; this list may not be complete and is subject to change as firms add or delete coverage of Enzon. Please note that any opinions, estimates or forecasts regarding Enzon's historical or predicted performance made by the analysts at these firms are theirs alone and do not represent opinions, forecasts or predictions of Enzon, Inc or its management. Enzon is providing this listing as a service to its stockholders, and does not by listing these firms imply its endorsement of or concurrence with such information, conclusions or recommendations. Interested persons must obtain copies of analysts' reports on their own; Enzon does not distribute these reports. Various of these firms may be market-makers in Enzon stock and/or hold other long or short positions in the stock, and may provide compensated services to Enzon.
| (ENZN) NASDAQ | |
| Last Trade | 10.580 |
| Change(%) |
0.17
|
| Volume | 208,700 |
| Sep 2, 2010 4:00 PM ET | |
Sign up to receive Enzon Pharmaceuticals Inc. financial information by email.
News
Details on upcoming events are not yet available.
click here to be notified of all upcoming events.


Really Simple Syndication is a format designed for sharing web content such as headlines. An RSS feed highlights fresh material for you, so you don't have to repeatedly check a site yourself for updates.
Company continues to progress as an innovative oncology
development company
--Company is transformed to be exclusively focused on its pipeline--
